Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: A case-matched comparison with unpurged cases by the European blood and marrow transplant lymphoma registry

Journal of Clinical Oncology

Volumn 14, Issue 9, 1996, Pages 2454-2464

  Williams, C D ^a   Goldstone, A H ^a   Pearce, R M ^a   Philip, T ^a   Hartmann, O ^a   Colombat, P ^a   Santini, G ^a   Foulard, L ^a   Gorin, N C ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0029775632     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.9.2454     Document Type: Article

References (29)

1. Takvorian T, Cannellos G, Ritz J, et al: Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med 316:1499-1505, 1987
2. Philip T, Hartman O, Biron P, et al: High-dose therapy and autologous bone marrow transplantation in partial remission after first line induction therapy for diffuse non-Hodgkin's lymphoma. J Clin Oncol 6:1118-1124, 1988
3. Gribben JG, Goldstone AH, Linch DC, et al: Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose chemotherapy. J Clin Oncol 7:1621-1629, 1989
4. Mills W, Chopra R, McMillan A, et al: BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol 13:588-595, 1995
5. Bast RC, DeFabritiis P, Lipton J, et al: Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res 45:499-503, 1985
6. DeFabritiis P, Bregni M, Lipton J, et al: Elimination of clonogenic Burkitt's cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement. Blood 65:1064-1070, 1985
7. Kvalheim G, Sorensen O, Fodstad O, et al: Immunomagnetic removal of B-lymphoma cells from human bone marrow: A procedure for clinical use. Bone Marrow Transplant 3:31-41, 1988
8. Weisdorf DJ, Haake R, Miller WJ, et al: Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: Clinical impact of immunophenotype and in vitro purging. Bone Marrow Transplant 8:135-142, 1991
9. Gribben JG, Freedman AS, Neuberg D, et al: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525-1533, 1991
10. Hurd DD, LeBien TW, Lasky LC, et al: Autologous bone marrow transplantation in non-Hodgkin's lymphoma: Monoclonal antibodies plus complement for ex vivo marrow treatment. Am J Med 85:829-834, 1988
11. Preijers FW, DeWitte T, Wessels JM, et al: Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma. Blood 74:1152-1158, 1989
12. Freedman AS, Takvorian T, Anderson KC, et al: Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: Very low treatment related mortality in 100 patients in sensitive relapse. J Clin Oncol 8:784-791, 1990
13. Peto R, Pike MD: Conservatism of the approximation (OE)2/E in the log-rank test for survival data or tumour incidence data. Biometrics 29:579-584, 1973
14. Cox DR: Regression models and life tables. J R Stat Soc 34B:187-220, 1983
15. The Non-Hodgkin's Lymphoma Pathologic Classification Project National Cancer Institute-sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical use. Cancer 49:2112-2135, 1982
16. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
17. Brenner MK, Rill DR, Moen RC, et al: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993
18. Gribben J, Nadler LM: Bone marrow purging for autologous bone marrow transplantation. Leuk Lymphoma 11:141-148, 1993 (suppl 2)
19. Favrot M, Philip I, Combaret V, et al: Monoclonal antibodies and complement purged autogratt in Burkitt lymphoma and lymphoblastic leukaemia. Bone Marrow Transplant 4:202-204, 1989
20. Sharp JG, Joshi SS, Armitage JO, et al: Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by culture techniques. Blood 79:1074-1080, 1992
21. Gribben JG, Freedman A, Woo SD, et al: All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplitiable breakpoint of bel-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275-3280, 1991
22. Berinstein NL, Reis MD, Ngan BY, et al: Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early stage and advanced stage follicular lymphoma. J Clin Oncol 11:1344-1352, 1993
23. Weiss LM, Warnke RA, Sklar J, et al: Molecular analysis of the t( 14; 18) chromosomal translocation in malignant lymphomas. N Engl J Med 317:1185-1189, 1987
24. Yimis JJ, Oken MM, Kaplan ME, et al: Distinctive chromosome abnormalities in histological subtypes of non-Hodgkin's lymphoma. N Engl J Med 307:1231-1236, 1982
25. Lambrechts AC, Hupkes PE, Dorssers LCJ, et al: Clinical significance of t(14; 18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol 12:1541-1546, 1994
26. Price CGA, Meerabux J, Murtagh S, et al: The significance of circulating cells carrying t( 14; 18) in long remission from follicular lymphoma. J Clin Oncol 9:1527-1532, 1991
27. Lazarus HM, Rowe JM, Goldstone AH: Does in vitro bone marrow purging improve the outcome after autologous bone marrow transplantation? J Hematother 2:457-466, 1993
28. Hartmann O, Blaise D, Michon J, et al: Results of a multicentric randomized clinical trial comparing peripheral blood stem cells and bone marrow graft in autologous transplantation. Blood 6:1821, 1995 (suppl 1)
29. Vose JM, Anderson JR, Kessinger A, et al: High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 11:1846-1851, 1993